NIH-funded research U01 cooperative agreement

Investigating youth-onset type 2 diabetes and its complications

Official title: Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes- NYU Clinical Center

Funded at New York University School of Medicine · NIH-11045701 · Data updated 2026-11-12

This study is looking at the causes and effects of type 2 diabetes in kids and teens to find out what makes it worse and how we can better treat it, so if you or someone you know is at risk, this research could help improve their care.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 17, 2023
Project endJanuary 31, 2029
Funding year2025
Award (this year)$750,256
NIH project number5U01DK135012-03
Project IDNIH-11045701 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children and adolescents at high risk for developing type 2 diabetes, particularly those with a family history or other risk factors.

Less likely to help

Patients who are not at risk for type 2 diabetes or who are already diagnosed with adult-onset diabetes may not benefit from this research.

What this research studies

This research focuses on understanding the unique characteristics of youth-onset type 2 diabetes (T2D), which is increasing in prevalence among children and adolescents. The study aims to identify risk factors and biomarkers that contribute to the rapid progression of this condition, including genetic, psychosocial, and environmental influences. By conducting a prospective cohort study of high-risk youth, researchers will gather data to develop predictive models that could lead to targeted therapies. The role of soluble receptors of Advanced Glycation End Products (sRAGE) in insulin resistance and beta-cell dysfunction will also be explored, as it may provide insights into the complications associated with youth-onset T2D.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for youth-onset type 2 diabetes, ultimately reducing its severity and associated complications.

How similar studies have gone: Previous research has shown success in understanding adult-onset type 2 diabetes, but the specific focus on youth-onset T2D and its unique pathophysiology is relatively novel.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Gallagher, Mary Patricia — New York University School of Medicine
  • Study coordinator: Gallagher, Mary Patricia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.